Triangle Securities Wealth Management Purchases 829 Shares of UnitedHealth Group Incorporated $UNH

Triangle Securities Wealth Management boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.9% in the second quarter, according to its most recent filing with the SEC. The firm owned 5,722 shares of the healthcare conglomerate’s stock after acquiring an additional 829 shares during the period. Triangle Securities Wealth Management’s holdings in UnitedHealth Group were worth $1,785,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in the stock. Citizens National Bank Trust Department raised its holdings in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after purchasing an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH boosted its position in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC lifted its stake in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after purchasing an additional 111 shares during the last quarter. Triumph Capital Management bought a new position in UnitedHealth Group in the 2nd quarter valued at approximately $1,324,000. Finally, Focus Partners Wealth raised its stake in shares of UnitedHealth Group by 5.3% during the first quarter. Focus Partners Wealth now owns 277,916 shares of the healthcare conglomerate’s stock valued at $145,559,000 after acquiring an additional 14,112 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $334.74 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a market cap of $303.16 billion, a PE ratio of 14.50, a PEG ratio of 2.23 and a beta of 0.45. The firm’s 50-day moving average price is $295.01 and its 200-day moving average price is $366.14.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period last year, the firm posted $6.80 EPS. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on UNH shares. Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. KeyCorp lowered their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Finally, Truist Financial upped their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.